Erythropoiesis occurs through several waves during embryonic development.
Introduction
Hematopoiesis is thought to develop in the mouse embryo through three distinct waves, characterized by the appearance of distinct hematopoietic progenitors at various time points (Yoder, 2014) . The first wave starts at E7 with the generation of primitive erythroid progenitors, some macrophages and megakaryocytes in the yolk sac (YS). These are still detected at E8.25, while at around E9 and E10.5 only some primitive macrophages persist. At E8.25 the second wave starts within the YS hemogenic endothelium (an endothelium with hematopoietic capacity), giving rise to erythromyeloid progenitors (EMPs). These are still detected at E9 and 10.5 of embryonic development, along with B and T lymphoid cells. Finally, the third wave is marked by the appearance of the first hematopoietic stem cells (HSCs), generated by the hemogenic endothelium in the aorta-gonad-mesonephros (AGM) region, around E10.5 (Yoder, 2014) .
Erythroid cells are generated by all of the aforementioned hematopoietic waves, supplying the rapidly growing embryo with oxygen and playing a role in vascular remodeling. The generation of the first erythrocyte progenitors (Erythroid colony forming cells: EryP-CFC) is transient, as they are no longer detected at E9.5 (Palis et al., 1999 , Isern et al., 2011 . Nonetheless, erythrocytes continue to mature in a semi synchronous cohort while circulating in the bloodstream (Fraser et al., 2007; Kingsley et al., 2004) . EMPs provide the growing organism with the second erythroid wave, prior and independently of the first HSCs emergence (McGrath et al., 2011) . They start colonizing the fetal liver at E10.5 and are still detectable in the YS until E11.5 (Palis et al., 1999) . Finally, a permanent third wave of erythroid cells is derived from HSCs that emerge from the AGM region at E10.5.
The overlap between distinct waves in the embryo as they enter circulation complicates the distinction between cell types. Nonetheless, the first erythroid wave can be distinguished from the rest due to their large nucleated cells and embryonic hemoglobin expression (mainly βH1 and εγ) (Palis, 2014) . However, once they enucleate, primitive erythroid cells are harder to distinguish, especially from erythroid derived EMPs as they also express βH1 globin in low amounts (McGrath et al., 2011) .
Additionally, primitive erythroid cells also show expression of adult globins (β1 and β2) even though at lower levels (Palis, 2014) . The first primitive erythroid progenitors were thought to arise from a mesodermal precursor (Ema et al., 2006; Isern et al., 2011) . On the other hand, EMPs and blood progenitor/stem cells generated in the later waves arise from mature endothelial cells with hemogenic potential, through a process termed Endothelial to Hematopoietic Transition (EHT) (Lancrin et al., 2009) . Interestingly, Stefanska et al have shown recently that primitive erythroid cells are generated in the yolk sac from hemogenic angioblast cells between E7.5 and E8.0 corresponding to the establishment of the capillary plexus (Garcia et al., 2014) , when the vasculature is still immature (Stefanska et al., 2017) .
The transcription factor RUNX1 plays a crucial role during EHT, being responsible for the loss of endothelial properties during blood generation (Lancrin et al., 2009 , Lancrin et al., 2012 , Thambyrajah et al., 2016 . Even though RUNX1 is dispensable for the generation of the first primitive erythroid cells, it plays a role in the maintenance of their morphology and correct gene expression (Yokomizo et al., 2008) . Additionally, the loss of RUNX1 is detrimental for the generation of EMPs and definitive hematopoietic cells derived from the hemogenic endothelium (Chen et al., 2009) . On the other hand, the exact role of the transcription factor GATA1 in EHT remains relatively unknown although it is clearly critical for erythroid cell formation in all three waves of blood cell formation.
In this study, we asked whether we could find in the yolk sac hemogenic endothelial cells specifically generating erythroid cells after E9.5; i.d. following vascular remodeling and production of a highly structured vascular network (Garcia et al., 2014) . To investigate this question, we used a previously described mouse model, in which GFP is used to label the transcription of the erythroid specific microRNAs miR144/451, which are expressed at all stages of erythroid differentiation (Rasmussen and O'Carroll, 2011) . We found a novel endothelial population that displays high expression of primitive erythroid genes, possibly representing a hemogenic endothelium subset prone to give rise to erythroid cells only. We suggest for the first time that primitive erythroid cells can be generated at later time points than previously described, after the onset of both primitive and definitive erythroid waves. In addition, we showed that this population can emerge in the absence of Runx1 and that the overexpression of Gata1 specifically in endothelium, could initiate the erythroid transcriptional program.
Results

A new cell population with endothelial and erythroid gene expression is found in the yolk sac between E9.5 and E12
We used a miR144/451 +/GFP mouse model, in which the erythroid lineage can be tracked by GFP expression (Rasmussen et al., 2011) to find out if an endothelial population with erythroid differentiation capacity exists between E9.5 and E12, i.e. after the primitive hematopoiesis wave. Yolk Sacs (YS) were isolated at different time points, dissociated and cells were subsequently analyzed for co-expression of VE-Cad (endothelial marker) and miR144/451-GFP by FACS ( Fig. 1A and B ). A population that expresses both GFP and the cell surface marker VE-Cad was found at E9.5. The percentage of VE-Cad + GFP + increases slightly from E9.5 (0.0116%), reaching its peak at E11.5 (0.0378%), before reducing slightly at E12. This population represents approximately 0.1% of all yolk sac VE-Cad + cells at all tested times. However since there is an increase in the total cell numbers in the YS as the embryo develops, there is a net increase of double positive cells during development (Fig. 1C ). As shown in Fig. 1C , a small number of double positive cells are found at E9.5 (≈21 cells), increasing significantly at E12 to an average of 425 cells in the YS.
We then used the miR144/451 +/GFP mouse model to visualize the VE-Cad + GFP + cells in the YS by fluorescence microscopy at E11.5 and found cells co-expressing VE-Cadherin and GFP (Fig. 1D ). These cells appear to be flat and elongated, thus exhibiting a morphology that is similar to endothelial cells.
Single cell transcriptome analysis demonstrated that miR144/451 + endothelial cells expressed the erythroid genes Gata1 and Hbb-bh1
The molecular signature of this newly discovered population was assessed by singlecell q-RT-PCR between E10.5 and E12 ( Fig. 2A) . We analyzed the gene expression of 95 genes, including endothelial, hematopoietic and erythroid specific markers (Table S1) , at the single cell level for the following populations: VE-Cad -GFP + , VE-Cad + GFPand VE-Cad + GFP + .
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Following single cell q-RT-PCR analysis, Principal Component Analysis (PCA) was performed. The VE-Cad -GFP + population was clearly distinct for the other two while VE-Cad + GFPand VE-Cad + GFP + cells were located closer to each other on the PCA plot ( Fig. 2B ). VE-Cad + GFPcells showed mainly high expression of endothelial genes (e.g. Cdh5, Kdr, Tek, Pecam1) but very little expression of hematopoietic and erythroid genes, while VE-Cad -GFP + population displayed high expression of erythroid specific markers (e.g. Gata1, Hbb-bh1, Epor) and no expression of endothelial genes (Fig. 2C ). For this reason, VE-Cad + GFPpopulation was named Endothelial Cells (EC) and VE-Cad -GFP + was denoted Erythroid (Ery). On the other hand, VE-Cad + GFP + cells had high expression of both endothelial and erythroid genes (e.g. Gata1, Epor and Hbb-bh1) and low expression of other hematopoietic markers (e.g. Itgam and Spi1). The majority of the cells within each population showed homogenous expression of the majority of genes. Nonetheless, certain hematopoietic (e.g. Itga2b, Itgab3, Ptprc and Gfi1b) and erythroid specific genes (Epor) were more variably expressed in some of the populations. While the VE-Cad + GFP + population had some Spi1 (myeloid marker) expression, the majority of the cells did not express this gene (Fig. 2C ). Likewise, Runx1 was expressed in a small subset of VE-Cad + GFP + (Fig. 2C ). Among the 99 VE-Cad + GFP + sorted cells, only a small subset (4 cells) expressed all together endothelial, hematopoietic and erythroid genes ( Fig. S1 ).
In summary, the VE-Cad + GFP + population could represent a new hemogenic endothelium population that may directly give rise to erythroid cells: the Erythroid Hemogenic Endothelial Cell (Ery-HEC) population.
Functional characterization of the Ery-HEC population
The function of the Ery-HEC population at E11.5 was evaluated by culturing these cells in the presence of OP9 stromal cells in a medium that supports the differentiation of hemogenic endothelium towards hematopoietic progenitors (Fig.   3A ). The OP9 cell line was previously described to support the generation of hematopoietic progenitors from ES cells and hemogenic endothelium (Nakano et al., 1994; Swiers et al., 2013) . To enable the growth of erythroid cells, we added erythropoietin (EPO) in the media. 500 Ery-HEC (VE-Cad + GFP + ), 1,000 EC (VE-Cad + GFP -) or 1,000 Ery (VE-Cad -GFP + ) cells from miR144/451 +/GFP E11.5 YS were FACS sorted on OP9 stromal cells. Following 4 days of culture in presence of EPO, the Ery population could not give rise to any colonies ( Fig. 3B and 3C ). However, EC were mostly generating white colonies (63% of the wells) and less often both white and green colonies (37% of the wells), which could be the progeny of EMP ( Fig. 3C ).
Indeed, in our sorting strategy, we have not excluded CD45 + cells, which are in the final phase of EHT in the yolk sac. As for the Ery-HEC population, we interestingly observed that the majority of cultures gave rise to GFP + colonies (45%) while wells producing only GFPor a mix of GFP + and GFPcells were observed less often (27.5% for each type of colonies). This would indicate that even though this population is capable of giving rise to erythroid cells, the generation of white blood cell types such as megakaryocytes is also possible (Fig. 3B ). This is consistent with the observation that rare cells in the Ery-HEC population are expressing Runx1 (Fig. 2 and Fig. S1 ), which could generate these white colonies.
Runx1 is dispensable for the generation of Ery-HEC population
Since the single-cell q-RT-PCR results showed that the expression of Runx1 in the Ery-HEC population was very rare (Fig. 2C ), we decided to thoroughly evaluate whether Runx1 is necessary for its generation. To achieve this, we generated Runx1 +/animals ( Fig. S2 ) and crossed them with miR144/451 +/GFP to obtain Runx1 +/-: miR144/451 +/GFP mice. Animals of this genotype were then crossed together to obtain Runx1 -/-: miR144 +/GFP and Runx1 -/-: miR144 GFP/GFP embryos. We then isolated YS from these embryos and sorted Ery-HEC by FACS for single-cell q-RT-PCR analysis ( Fig. 4A ). We were able to obtain 24 cells, with an expression profile highly similar to the wild type Ery-HEC cells ( Fig. 4B and 4C) , showing that Runx1 is dispensable for the generation of this population.
The Ery-HEC population expresses genes characteristic of the primitive erythroid lineage
We have shown that the Ery-HEC population could be identified using the miR144/451 +/GFP mouse model together with the VE-Cad marker. The expression of Hbb-bh1 suggests that these cells have a signature compatible with primitive erythropoiesis. However, it has been shown that this gene is also expressed by fetal definitive erythroid cells (Erythron data base- Kingsley et al. 2013) . Therefore, to have a more complete understanding of the nature of these cells, we performed RNA sequencing. We sorted Ery-HEC cells from miR-144/451 +/GFP E11.5 YS and used EC and Ery populations as controls ( Fig. 5A ). We detected a total of 13,081 expressed genes (Supplementary File S4).
The PCA showed that the different sample groups have very distinct expression profiles ( Fig. 5B ). There were 4,115 differentially expressed genes (|log 2 fold change|>1, p-value<0.01) between EC vs Ery, 2,188 between Ery-HEC vs Ery and 513 between Ery-HEC vs EC. Using these gene lists, we performed Gene Ontology (GO) analysis ( Fig. 5C , Supplementary File S4 and Table S2 ).
The Cell-Cell Adherens Junction GO term (GO:005913) was more enriched for the two VE-Cad + populations compared to the Ery population consistent with the necessity of endothelial cells to establish physical links to adhere to each other.
Moreover, EC and Ery-HEC are clearly expressing endothelial genes such as Cdh5
and Cldn5 (Fig. 5D ). The genes coding for the key transcription factors Erg, Fli1, Gata2, Lmo2, Runx1 and Tal1 were all expressed in the endothelial populations when only Lmo2, Tal1 and Runx1 could be detected in the erythroid subgroup ( Fig. 5D ). In line with the erythroid phenotype of the Ery population, there was a significant increase of genes associated with Heme Biosynthetic Process GO term (GO:0006783), e.g. Alad and Alas2, which is a crucial step in the production of hemoglobin. These genes were also significantly expressed in the Ery-HEC population supporting the idea that they could make hemoglobin. Interestingly, genes associated with cell cycle (GO:0007049) were more highly expressed in Ery population compared to the two endothelial populations suggesting a higher proliferative capacity. We also confirmed that Ery-HEC and Ery cells express miR144 which was used as a marker for both populations and lack Runx1 expression as shown before ( Fig. 5D ).
Finally, to know if the Ery-HEC cells are associated with the primitive erythroid program, we looked for specific primitive genes such as Aqp3, Aqp8 and Lmx1a (Erythron data base - Kingsley et al. 2013 ) as well as embryonic hemoglobin genes (Hba-x, Hbb-bh1 and Hbb-y). They were both expressed in the Ery-HEC and Ery populations. Interestingly, the adult hemoglobin Hbb-b1 was not detected. Moreover, the genes coding for Bcl11a and Sox6, two transcription factors involved in the hemoglobin switching (Sankaran et al. 2009 , Yi et al. 2006 were not expressed ( Fig.   5D ). Overall, this implies that the Ery-HEC population could be a source of primitive erythroid cells at much later stages than previously thought (Isern et al., 2011; Palis et al., 1999) .
Gata1 can induce the erythroid program in endothelial cells
The existence of a putative HE population specific to the erythroid lineage prompted us to ask how this program could be initiated in vascular cells. Our main candidate for this was Gata1 because it has been described as a pioneer transcription factor to open silent chromatin. Indeed, ectopic expression of Gata1 in monocytes initiated erythroid and megakaryocyte gene expression (Kulessa et al., 1995; Visvader et al., 1992) . In addition, Gata1, Tal1, Lmo2 and cMyc have been shown to reprogram fibroblasts into embryonic erythroid progenitor (Capellera- Garcia et al., 2016) . Since all endothelial cells express already Tal1 and Lmo2, we reasoned that the induction of Gata1 expression might be enough to initiate the erythroid program in these cells.
To test this hypothesis, we used the Embryonic Stem Cell (ESC) differentiation into embryonic blood cells, a faithful model of yolk sac hematopoiesis. We first checked if endothelial cells co-expressing Gata1 and Hbb-bh1 could be produced from ESCs.
We first differentiated the cells into Flk1 + mesodermal cells containing the in vitro equivalent of hemangioblast. These cells were later grown in the hemangioblast differentiation assay in the presence of IL6 and VEGF. After 1.5 days, VE-Cad + CD41endothelial cells were FACS-sorted and analyzed by single cell q-RT-PCR ( Fig. S3 ). Out of 165 endothelial cells, 9 co-expressed Gata1 and Hbb-bh1
showing that these cells could also be produced in vitro from ES cells.
We next generated a doxycycline (dox) -inducible Gata1 ESC line ( Fig. 6A ) to test the role of Gata1 in the initiation of the erythroid program in endothelial cells. We demonstrated by western blot that the GATA1 protein was successfully expressed following dox treatment of ES cells (Fig. 6B ). We next induced Gata1 expression during the hemangioblast differentiation assay and analyzed the phenotype of the cells after 1, 2 and 3 days of dox treatment. There was a significant reduction of endothelial cells frequency at all time points ( Fig. 6C ). There was also an increase of CD41 + frequency especially after one day of culture. The frequency of CD41 + cells was quite similar between the -dox and +dox conditions later on ( Fig. 6C ). To have a more detailed understanding of Gata1 expression impact in endothelial cells, we FACSsorted VE-Cad + CD41cells from day 1.5 of hemangioblast differentiation assay. We also isolated VE-Cad + CD41 + cells, which are at a step further in the EHT and coexpress both endothelial and blood genes (Bergiers et al., 2018) . These cells were cultured in hemogenic endothelium (HE) mix in absence or presence of dox for 48 hours (Fig. 6D ). The q-RT-PCR analysis showed that the Gata1 over-expression led to the up-regulation of Itgb3 (expressed by early progenitors and megakaryocytes), Epor, Gfi1b, Hbb-y (expressed by primitive and fetal erythrocytes) and Hba-x (specific to primitive erythroid cells) in the VE-Cad + CD41 + cell population suggesting the induction of the erythroid program (Fig. 6E) . In contrast, the myeloid (Spi1) and endothelial (Cdh5 and Kdr) programs were down-regulated (Fig. 6E ). The impact of Gata1 over-expression on VE-Cad + CD41cells was less strong than on the other population. However, we observed a similar up-regulation of Itgb3 and Gfi1b genes ( Fig. 6E ). Hbb-y and Hba-x expression was also higher following Gata1 induction although the change was not statistically significant (Fig. 6E ). This was mostly due to large variability between the biological replicates ( Fig. S4 ). Finally, CFU-assays were done in absence of dox following the HE cultures and we found a consistent and significant increase in the number of erythroid colonies (between 2 and 4-fold) following Gata1 over-expression for both populations (Fig. 6F) . These results show that Gata1 can indeed trigger the erythroid program in endothelial cells.
Discussion
In this study we have used single cell gene expression analysis to identify and characterize a new and rare population, Ery-HEC, with both endothelial and erythroid characteristics. Chen and colleagues previously suggested the existence of different types of hemogenic endothelium for EMPs and HSCs (Chen et al., 2011) . However, this is the first time an endothelial population with apparent restricted primitive erythroid potential is found in the vasculature at such a late embryonic stage.
This was also the first time that this type of population was detected after the onset of both the primitive and EMP generating erythroid waves. While the first erythroid progenitors (EryP-CFC) are found in the Yolk Sac as late as E9.0, EMPs start to emerge at E8.25 from the newly formed vasculature (Frame et al., 2015; Palis et al., 1999) . This new Ery-HEC population was observed in the YS from E9.5, increasing in numbers until E12, concomitant with primitive erythroid enucleation and the release of the first definitive erythroid cells derived from EMP, into circulation by the fetal liver (Kingsley et al., 2004) .
We further showed that the Ery-HEC population expresses genes specific to the primitive erythroid lineage (e.g. Aqp3, Aqp8 and Lmx1a), (Kingsley et al., 2013) . In addition, we showed that similarly to the first erythroid progenitors, Ery-HEC population could emerge in the absence of Runx1. Furthermore, Ery-HEC cells gave rise to either erythroid-cells (miR144/451-GFP + ) ex vivo but also white blood colonies. Even though miR144/451 is expressed mainly in erythroid cells, it has also been shown to be present in a small fraction of CMP and PreMegE (Rasmussen and O'Carroll, 2011) . Moreover, a small fraction of the Ery-HEC population expressed Runx1. Consequently, the Ery-HEC population might not exclusively give rise to primitive erythroid cells but could also be a source megakaryocytic progenitors. This could explain the white colonies observed in our OP9 culture (Fig. 3) .
Even though the number of Ery-HEC cells found in vivo is quite low, these cells could later proliferate after losing their endothelial properties and become erythroid progenitors. Indeed we found that Erythroid cells had a higher expression level of cell-cycle genes compared to endothelial populations (Fig. 5 ).
Direct reprogramming of fibroblasts towards cells expressing primitive erythroid genes, has been recently shown, using the minimal combination of the transcription factors Gata1, Lmo2, Tal1 and c-Myc (Capellera- Garcia et al., 2016) . Here, we demonstrate that the erythroid transcriptional program (both primitive and definitive as suggested by Hba-x and Hbb-y upregulation) could be activated in endothelial cells by overexpressing Gata1 specifically.
In conclusion, this newly described hemogenic population could constitute a novel pathway for the generation of erythroid cells and megakaryocytic progenitors at later stages in mouse development. The early phase of specification of this hemogenic population requires Gata1 but not Runx1. However, the role of Runx1 later in the production of erythroid and megakaryocytes remains unclear (Fig. 7) .
Finally, the fact that Gata1 overexpression could induce the erythroid program in endothelial cells without using Myc, an oncogene, could be applied in medical applications aiming at producing red blood cells from endothelial cells instead of fibroblasts.
Materials and Methods
Mouse lines, generation of Runx1 null allele mice and embryo dissection
The miR144/451 +/GFP mice were kindly provided by Dr. Dónal O'Carroll (University of Edinburgh) and were previously described elsewhere (Rasmussen et al., 2011) while Runx1 +/mice were generated as followed: The Runx1 gene targeting strategy 
Embryo genotyping
Mouse embryos were genotyped using KAPA Mouse genotyping kit (KAPA Biosystems, KK7352). For each embryo the head was dissected and incubated at 75°C for 10min in an eppendorf tube with 10µl of 10x KAPA extract buffer, 2µl of KAPA Express Extract Enzyme and 88µl of deionized H 2 O, in a total volume of 100µl. After incubation, tubes were vortexed briefly and centrifuged at maximum speed for 1min. For the PCR reaction 1µl of the supernatant was used together with 12.5µl of 2X KAPA2G mix, genotyping primers (10µM) and brought up to a final volume of 25µl using deionized H 2 O. PCR was performed in accordance to the protocol suggested in the kit and a 2% agarose gel was used for electrophoresis.
The primers for miR144/451 +/GFP and Runx1 +/genotyping are listed below:
The WT band is 330 bp while the null band is 401 bp.
The WT band is 227 bp, the Flox band 327 bp while the null band is 378 bp.
Generation of inducible Gata1 ESC line
The inducible Gata1 (iGata1) ESC line was generated using the inducible cassette exchange method described previously (Iacovino et al., 2011; Vargel et al., 2016) .
The Gata1 coding sequence was tagged in 5' with a Flag-tag, synthetized and cloned into a pUC57 Simple plasmid by the GenScript Gene Synthesis Service (http://www.genscript.com/ gene_synthesis.html). The Gata1 coding sequence was then cloned from the pUC57 Simple into the p2lox plasmid (Iacovino et al. 2011 ).
The subsequent p2lox plasmid was used to transfect A2lox.Cre ESC line (Iacovino et al. 2011) to generate the inducible Gata1 ESC line as previously described (Vargel et al., 2016) .
Western Blotting
Proteins were extracted from each sample (+Dox and -Dox) of iGata1 ES cells (approximately 6 million cells used) and 15 µg of each subjected to electrophoresis through a NuPAGE® Tris-Acetate gel (Life technologies, cat. #LP0001) transferred onto nitrocellulose and probed with anti-Gata1 antibody N6 (Santa Cruz Biotech, cat.
#sc-265) and an anti-rat secondary antibody (VWR, cat. #95058-824) before detection using chemi-luminescence.
ES cell culture
Runx1 +/hCD4 (Sroczynska et al. 2009) After 3.25 days of culture, EBs were harvested for hemangioblast assay as described previously (Vargel et al. 2016) . Briefly, Flk1 + cells from day 3.25 EBs were sorted using magnetic sorting (MACS®, Miltenyi Biotech) and plated in BL-CFC mix composed of IMDM, 10% FBS, 1% L-glutamine, 0.6% transferrin, 0.03% MTG, 0.5% ascorbic acid, 15% D4T supernatant, 0.05% VEGF (10µg/ml) (R&D, 293-VE-010), 0.1% IL-6 (10µg/ml) (R&D, 406-ML).
For hemogenic endothelium culture, FACS-sorted VE-Cad + CD41and VE-Cad + CD41 + cells were cultured on gelatinized plate at a density of 0.2 × 10 6 cells per cm 2 (cells isolated from day 1.5 BL-CFC culture). The media was composed of IMDM supplemented with 10% FBS (same as BL-CFC mix), 1% L-glutamine, 0.6% 30 mg/ml transferrin, 0.3% 0.15 M MTG, 0.5% 5 mg/ml ascorbic acid, 0.024% 100 µg/ml LIF (EMBL-Heidelberg), 0.5% 10 µg/ ml SCF (R&D systems, cat. #455-MC), and 0.1% 10 µg/ml Oncostatin M (R&D systems, cat. #495-MO).
Hematopoietic Colony Forming Unit Assay
Cells from HE day2, previously treated with dox or not, were harvested and plated at a given density per dish (35x10mm, Corning) with 3ml of CFU medium. This medium contains IMDM + 15% PDS serum replacement (Antech), 10% PFMH-II (GIBCO, 12040-077), 1%L-Glutamine, 0.6% Transferrin, 0.05mg/ml Ascorbic acid, 0.03% MTG, 0.05µg/ml SCF (Peprotech, 52250-03), 0.025µg/ml IL-3 (R&D, 403-ML), 0.025µg/ml GM-CSF (R&D, 425-ML), 0.005µg/ml IL-11(R&D, 418-ML), 0.02 µg/ml EPO (R&D, 959-ME-010), 0.01µg/ml IL-6, 0.025µg/ml TPO (R&D, 488-TO-005), 0.005µg/ml MCSF (R&D, 416-ML-010) and 55% of 500g/L methylcellulose (VWR, which is added after the liquid components and the cells are mixed together. Three dishes (corresponding to 3 repeats) were prepared in total for each cell sample. Colonies were counted and averaged for each sample, based on their morphology (white, red and a mix of both mix) after 5 days of culture.
The cell counts from the CFU-assay experiment were analysed with a generalized linear model using quasi-Poisson distribution and logarithm as link function. One variable for the conditions (+dox and -dox) and a second variable to account for batch effects were used as predictor variables. In addition, the model included an offset to model rates instead of counts while accounting for differences in the total number of plated cells. The analysis was done separately for each of the two subsets of cells. The significance and fold-change of the contrast +dox versus -dox were reported.
Immunostaining
Whole-mount immunostaining protocol was adapted from a previously described protocol (Corada et al., 2013) . Whole 3D view of dissected embryo was performed using a Z1 light sheet microscope (Zeiss, Germany). Upon staining whole embryos were embedded in 2% low melting point Agarose (LMA, Promega) /PBS and placed at 4°C for agarose polymerization. Subsequently embryos were dissected sagittally, the embryo was scooped off and the 2 parts of the yolk sac were filled with 1% LMA and set at 4°C for polymerization. Each part was dissected in other 4 pieces, which were attached on a syringe tip and hanged up into the imaging chamber of the Lightsheet Z1. Solid-state laser exciting at 488 and 641 were used as illumination sources and 5X objective was used for imaging.
Upon imaging the dissected YS was immersed in PBS solution to allow agarose to solubilize, and mounted flat onto a glassslide for further analysis. Mosaic reconstruction was performed at 20X on a DSD2 spinning disk confocal (Andor)
using LEDs exciting respectively at 480 and 640 nm. The entire montage was carefully analyzed in xyz, and putative double positive cells (VE-Cad + GFP + ) were imaged at higher resolution in xyz to confirm their co-expression of GFP and VE-Cadherin 647 (clone BV13 unconjugated, eBiosciences, 14-1441-81). A list of the antibodies used in FACS experiments is described below: 
Flow cytometry and cell sorting
Runx1
CTCCGTGCTACCCACTCACT ATGACGGTGACCAGAGTGC
Spi1
GGGATCTGACCAACCTGGA AACCAAGTCATCCGATGGAG
The relative RNA quantity was calculated the following way for each gene: CT target gene -CT reference gene (Ppia) generating Delta CT values ( Figure S4) . The results obtained from the q-RT-PCR as shown in Figure 6E were analysed with a 2-way ANOVA model accounting for the condition and the batch. The fold-change of the CT values and its significance between the +dox and -dox conditions was calculated for each gene separately. The Benjamini-Hochberg method was applied to adjust the p-values while correcting for multiple testing.
Single cell q-RT-PCR
Single cell expression profiling was performed using a nested primer approach following the Fluidigm Advanced Development Protocol (section 41), in which 2 pairs of primers are used for each gene, one for reverse transcription and the other for qPCR. In brief, single cells from E10.5-12 YS and E11.5 AGM regions were FACSsorted into 96-well plates (Bio-Rad Hard-Shell, HSP9611), containing 5µl of 2x reaction mix (Invitrogen, 11753) per well. The plates were shortly snap-frozen on dry ice after sorting and stored at −80°C.
Reverse transcription and nested-PCR were performed as previously described (Bergiers et al, 2018) . The primers used for the 95 genes ( Supplementary Table 1 ) are the same as in Bergiers et al (Bergiers et al, 2018) .
Hematopoietic progenitor Assay-OP9
Sorted cells from miR144/451 +/GFP E11.5 YS were co-cultured with OP9 stromal cells (OP9 ATCC ® CRL-2749TM) in 96 well plates with a modified version of hemogenic endothelium medium, containing IMDM 10% OP9 serum (ATCC ® 30-2020), 1% L-Glutamine, 0.5% Ascorbic Acid, 0.6% Transferrin, 0.03% MTG, 0.05mg/ml Ascorbic acid, 0.024µg/ml LIF, 0.05µg/ml SCF, 0.025µg/ml IL-3, 0.005µg/ml IL-11, 0.01µg/ml IL-6, 0.01 µg/ml OncostatinM, 0.001µg/ml bFGF (R&D, 233-FB) and 0.02 µg/ml EPO.
The OP9 stromal cells were plated the day before in 96 well plates previously treated with gelatin, at a final density of 3,000 cells per well and kept with OP9 medium. OP9 medium was replaced with the modified hemogenic endothelial medium before sorting.
RNA sequencing
Cells from miR144/451 +/GFP E11.5 YS were FACS sorted into tube strips with lysis buffer containing 0.2% Triton X-100, oligo-dT Primer and dNTP mix and after snap frozen on dry-ice. Furthermore RT & template-switching, PCR preamplification (14 cycles for 25-cells and 16 cycles for 5-cells and 11-cells samples) and Nextera
Library preparation were performed as described in the Smart Seq2 protocol (Picelli et al., 2014) .
Sequencing data was analysed with the aid of EMBL Galaxy tools (galaxy.embl.de (Afgan et al., 2016) ) for adaptor clipping (FASTX), mapping (RNA STAR) and obtaining raw gene expression counts (htseq-count NA means "not applicable" because the indicated genes were not enriched for the particular set of genes (i.d. there were no available p-values). (D) Expression heatmap of selected genes. Gene names followed by "*" indicate primitive erythroid genes.
Figure Legends
See also Table S2 and Supplementary File S4. 
Figure 7: Model
The scheme describes the model derived from the results of the experiments shown in this paper. Gata1 is crucial to initiate the erythroid program and the expression of miR144/451 microRNAs and remains expressed throughout the differentiation. The resulting Ery-HEC population would produce erythroid cells and possibly megakaryocytes. Runx1 is not necessary for the generation of Ery-HEC but its function for the later phases of differentiation remains unclear.
